Clinical Trial Update: HAIC Combined With Toripalimab and Donafenib for Advanced BTC [Phase 2]

View source ↗

Summary

Phase 2 clinical trial assessing hepatic arterial infusion chemotherapy (HAIC) combined with toripalimab and donafenib for biliary tract adenocarcinoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Biliary Tract Adenocarcinoma

Drugs mentioned

• Donafenib (donafenib)
• HAIC (hepatic artery infusion chemotherapy)
• Toripalimab (Toripalimab)

Snippet

Sponsor: Lu Wang, MD, PhD | Conditions: Biliary Tract Adenocarcinoma | Phase 2 | Status: UNKNOWN